|
Name |
N-(4-Oxocyclohexyl)acetamide
|
Molecular Formula | C8H13NO2 | |
IUPAC Name* |
N-(4-oxocyclohexyl)acetamide
|
|
SMILES |
CC(=O)NC1CCC(=O)CC1
|
|
InChI |
InChI=1S/C8H13NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h7H,2-5H2,1H3,(H,9,10)
|
|
InChIKey |
WZEMYWNHKFIVKE-UHFFFAOYSA-N
|
|
Synonyms |
N-(4-Oxocyclohexyl)acetamide; 27514-08-5; 4-Acetamidocyclohexanone; 4-acetamido-cyclohexanone; 4-(Acetylamino)cyclohexanone; Acetamide, N-(4-oxocyclohexyl)-; N-(4-oxocyclohexyl) acetamide; 4-n-acetyl-amino-cyclohexanone; MFCD03703462; 4-n-acetylamino cyclohexanone; n-(4-oxo-cyclohexyl)-acetamide; 4-Aminocyclohexanone, N-acetyl-; n-acetylaminocyclohexanone; 4-acetamido cyclohexanone; 4-acetylamino-cyclohexanone; EC 608-106-4; N-(4-Oxocyclohexyl)acetamde; SCHEMBL658632; 4-Acetamidocyclohexanone, 97%; N-(4-Oxocyclohexyl)acetamide #; DTXSID40337089; CS-M1862; ZINC2510356; BBL034880; STL426087; AKOS001372662; AC-5742; GS-3222; SB17822; SY020514; DB-007715; AM20070523; FT-0602731; EN300-27282; 514A085; J-523073; Z235341209; 4-N-acetyl-aMino-cyclohexanone;N-(4-Oxocyclohexyl)acetaMide;4-acetaMino cyclohexanone
|
|
CAS | 27514-08-5 | |
PubChem CID | 538565 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 155.19 | ALogp: | -0.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.615 |
Caco-2 Permeability: | -4.517 | MDCK Permeability: | 0.00002260 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.643 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.024 |
30% Bioavailability (F30%): | 0.014 |
Blood-Brain-Barrier Penetration (BBB): | 0.984 | Plasma Protein Binding (PPB): | 19.58% |
Volume Distribution (VD): | 0.699 | Fu: | 85.75% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.129 |
CYP2C19-inhibitor: | 0.032 | CYP2C19-substrate: | 0.129 |
CYP2C9-inhibitor: | 0.013 | CYP2C9-substrate: | 0.343 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.255 |
CYP3A4-inhibitor: | 0.007 | CYP3A4-substrate: | 0.168 |
Clearance (CL): | 2.988 | Half-life (T1/2): | 0.827 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.3 |
Drug-inuced Liver Injury (DILI): | 0.067 | AMES Toxicity: | 0.364 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.247 |
Skin Sensitization: | 0.129 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.087 |
Respiratory Toxicity: | 0.027 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004122 | 0.302 | D04JPJ | 0.263 | ||||
ENC000567 | 0.255 | D07WFK | 0.247 | ||||
ENC001082 | 0.255 | D0Z8SF | 0.239 | ||||
ENC001339 | 0.255 | D0R7WU | 0.231 | ||||
ENC000828 | 0.245 | D07BSQ | 0.221 | ||||
ENC001302 | 0.244 | D0E1XL | 0.216 | ||||
ENC001191 | 0.241 | D0Q4YK | 0.213 | ||||
ENC003574 | 0.239 | D06FPQ | 0.209 | ||||
ENC000456 | 0.238 | D0R9BG | 0.206 | ||||
ENC001256 | 0.234 | D0F1UL | 0.205 |